AAAAAA
Results:
1-20
|
Results: 20
Authors:
KIM KS
MOQUIN RV
QIAN LG
MORRISON RA
SEILER SM
ROBERTS DGM
OGLETREE ML
YOUSSEF S
CHONG S
Citation: Ks. Kim et al., PREPARATION OF ARGATROBAN ANALOG THROMBIN INHIBITORS WITH REDUCED BASIC GUANIDINE MOIETY, AND STUDIES OF THEIR CELL-PERMEABILITY AND ANTITHROMBOTIC ACTIVITIES, Medicinal chemistry research, 6(6), 1996, pp. 377-383
Authors:
ZHANG RG
OGLETREE ML
MORELAND S
Citation: Rg. Zhang et al., CHARACTERIZATION OF THROMBOXANE A(2) PROSTAGLANDIN ENDOPEROXIDE RECEPTORS IN AORTA/, European journal of pharmacology, 317(1), 1996, pp. 91-96
Authors:
VESTERQVIST O
SARGENT CA
GROVER GJ
OGLETREE ML
Citation: O. Vesterqvist et al., MYOCARDIAL CALCIUM-INDEPENDENT PHOSPHOLIPASE A(2) ACTIVITY DURING GLOBAL-ISCHEMIA IN ISOLATED RABBIT HEARTS, Cardiovascular Research, 31(6), 1996, pp. 932-940
Authors:
TESFAMARIAM B
OGLETREE ML
Citation: B. Tesfamariam et Ml. Ogletree, DISSOCIATION OF ENDOTHELIAL-CELL DYSFUNCTION AND BLOOD-PRESSURE IN SHR, American journal of physiology. Heart and circulatory physiology, 38(1), 1995, pp. 189-194
Authors:
GROVER GJ
PARHAM CS
YOUSSEF S
OGLETREE ML
Citation: Gj. Grover et al., PROTECTIVE EFFECT OF THE SEROTONIN RECEPTOR ANTAGONIST CINANSERIN IN 2 CANINE MODELS OF PACING-INDUCED MYOCARDIAL-ISCHEMIA, Pharmacology, 50(5), 1995, pp. 286-297
Authors:
GOMOLL AW
SCHUMACHER WA
OGLETREE ML
Citation: Aw. Gomoll et al., DOSE-RELATED CARDIOPROTECTION BY IFETROBAN IN RELATION TO INHIBITION OF THROMBOSIS AND EX-VIVO PLATELET-FUNCTION, Pharmacology, 50(2), 1995, pp. 92-110
Authors:
GOMOLL AW
GROVER GJ
OGLETREE ML
Citation: Aw. Gomoll et al., MYOCARDIAL SALVAGE EFFICACY OF THE THROMBOXANE RECEPTOR ANTAGONIST IFETROBAN IN FERRETS AND DOGS, Journal of cardiovascular pharmacology, 24(6), 1994, pp. 960-968
Authors:
GROVER GJ
SCHUMACHER WA
OGLETREE ML
Citation: Gj. Grover et al., THROMBOXANE RECEPTOR ANTAGONIST BMS-180291, BUT NOT ASPIRIN, REDUCES THE SEVERITY OF PACING-INDUCED ISCHEMIA IN DOGS, Journal of cardiovascular pharmacology, 24(3), 1994, pp. 493-499
Authors:
GOMOLL AW
OGLETREE ML
Citation: Aw. Gomoll et Ml. Ogletree, FAILURE OF ASPIRIN TO INTERFERE WITH THE CARDIOPROTECTIVE EFFECTS OF IFETROBAN, European journal of pharmacology, 271(2-3), 1994, pp. 471-479
Authors:
SWANSON BN
MANNING JA
OGLETREE ML
UDERMAN H
SKOLODA SJ
DELANEY CL
LIAO W
Citation: Bn. Swanson et al., EFFECT OF BMS-180291, A LONG-ACTING THROMBOXANE A2 RECEPTOR ANTAGONIST, ON PLATELET-FUNCTION IN HEALTHY-MEN, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 202-202
Authors:
TESFAMARIAM B
OGLETREE ML
Citation: B. Tesfamariam et Ml. Ogletree, DISSOCIATION OF ENDOTHELIUM DYSFUNCTION AND BLOOD-PRESSURE, Circulation, 90(4), 1994, pp. 285-285
Authors:
TESFAMARIAM B
OGLETREE ML
Citation: B. Tesfamariam et Ml. Ogletree, DISSOCIATION OF ENDOTHELIUM DYSFUNCTION AND BLOOD-PRESSURE, Circulation, 90(4), 1994, pp. 285-285
Authors:
VESTERQVIST O
SARGENT CA
GROVER GJ
WARRACK BM
DIDONATO GC
OGLETREE ML
Citation: O. Vesterqvist et al., CHARACTERIZATION OF RABBIT MYOCARDIAL PHOSPHOLIPASE A(2) ACTIVITY USING ENDOGENOUS PHOSPHOLIPID SUBSTRATES, Analytical biochemistry, 217(2), 1994, pp. 210-219
Authors:
PHILLIPSON DW
TYMIAK AA
TUTTLE JG
HARTL KS
HARPER TW
BOLGAR MS
ALLEN GT
OGLETREE ML
Citation: Dw. Phillipson et al., ISOLATION AND IDENTIFICATION OF LYSOPHOSPHATIDYLCHOLINES AS ENDOGENOUS MODULATORS OF THROMBOXANE RECEPTORS, Journal of lipid mediators, 7(2), 1993, pp. 155-167
Authors:
SCHUMACHER WA
HERAN CL
STEINBACHER TE
YOUSSEF S
OGLETREE ML
Citation: Wa. Schumacher et al., SUPERIOR ACTIVITY OF A THROMBOXANE RECEPTOR ANTAGONIST AS COMPARED WITH ASPIRIN IN RAT MODELS OF ARTERIAL AND VENOUS THROMBOSIS, Journal of cardiovascular pharmacology, 22(4), 1993, pp. 526-533
Authors:
GOMOLL AW
OGLETREE ML
Citation: Aw. Gomoll et Ml. Ogletree, MYOCARDIAL SALVAGE EFFICACY OF A THROMBOXANE RECEPTOR ANTAGONIST, SQ-30,741, IN RELATION TO INHIBITION EX-VIVO OF PLATELET-FUNCTION IN THE FERRET, Prostaglandins, 46(3), 1993, pp. 233-242
Authors:
SCHUMACHER WA
STEINBACHER TE
HERAN CL
SEILER SM
MICHEL IM
OGLETREE ML
Citation: Wa. Schumacher et al., COMPARISON OF THROMBIN ACTIVE-SITE AND EXOSITE INHIBITORS AND HEPARININ EXPERIMENTAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1237-1242
Authors:
PREMCHANDRAN RH
OGLETREE ML
FRIED J
Citation: Rh. Premchandran et al., SYNTHESIS OF A THROMBOXANE-A(2) RECEPTOR ANTAGONIST POSSESSING THE DIOXABICYCLOHEPTANE NUCLEUS OF TXA(2), Journal of organic chemistry, 58(21), 1993, pp. 5724-5731
Authors:
SARGENT CA
VESTERQVIST O
OGLETREE ML
GROVER GJ
Citation: Ca. Sargent et al., EFFECTS OF ENDOGENOUS AND EXOGENOUS LYSOPHOSPHATIDYLCHOLINE IN ISOLATED-PERFUSED RAT HEARTS, Journal of Molecular and Cellular Cardiology, 25(8), 1993, pp. 905-913
Authors:
MISRA RN
BROWN BR
SHER PM
PATEL MM
HALL SE
HAN WC
BARRISH JC
KOCY O
HARRIS DN
GOLDENBERG HJ
MICHEL IM
SCHUMACHER WA
WEBB ML
MONSHIZADEGAN H
OGLETREE ML
Citation: Rn. Misra et al., INTERPHENYLENE 7-OXABICYCLO[2.2.1]HEPTANE OXAZOLES - HIGHLY POTENT, SELECTIVE, AND LONG-ACTING THROMBOXANE A(2)-RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(10), 1993, pp. 1401-1417
Risultati:
1-20
|